Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function.

Saved in:
Bibliographic Details
Title: Detection of signature double-negative T cells is a predictive marker to identify autoimmune lymphoproliferative syndrome associated with FAS loss of function.
Authors: Eisenhauer N; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Miano M; Hematology Unit, Department of Pediatric Hematology/Oncology, IRCCS Istituto Giannina Gaslini, Genova, Italy., Naumann-Bartsch N; Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany., Leyh J; Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany.; Department of Pediatric Hematology and Oncology, Klinik Hallerwiese-Cnopfsche Kinderklinik, Nürnberg, Germany., Dell'Orso G; Hematology Unit, Department of Pediatric Hematology/Oncology, IRCCS Istituto Giannina Gaslini, Genova, Italy., Aigner M; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Fecker G; Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany., Hinze C; Department of Pediatric Rheumatology and Immunology, University Hospital Münster, Münster, Germany., Wittkowski H; Department of Pediatric Rheumatology and Immunology, University Hospital Münster, Münster, Germany., Bruns H; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Zierk J; Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany., Metzler M; Department of Pediatrics, University Hospital Erlangen, Erlangen, Germany., Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK., Graw F; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Mackensen A; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany., Völkl S; Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany.
Source: American journal of hematology [Am J Hematol] 2024 May; Vol. 99 (5), pp. 997-1000. Date of Electronic Publication: 2024 Mar 14.
Publication Type: Letter; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7610369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-8652 (Electronic) Linking ISSN: 03618609 NLM ISO Abbreviation: Am J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1096-8652
DOI:10.1002/ajh.27286